Evidence map›Paper›PMID 28398466›Full record

ArticleHuman molecular genetics2017

Novel nesprin-1 mutations associated with dilated cardiomyopathy cause nuclear envelope disruption and defects in myogenesis.

Can Zhou, Chen Li, Bin Zhou, Huaqin Sun, Victoria Koullourou, Ian Holt, Megan J Puckelwartz, Derek T Warren, Robert Hayward, Ziyuan Lin and 7 more

Open access · hybridAbstract read
In one paragraph

Article in Human molecular genetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed, 2 pooled it
5.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 2 syntheses or guidelines pooled it, 99 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. IntronicInternational journal of molecular sciences · 2025
    Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Nucleus Mechanosensing in Cardiomyocytes.International journal of molecular sciences · 2023
    Review
  17. Article
  18. Review
  19. Article
  20. Article

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 10 institutions in 5 countries.

Can ZhouKing's College London British Heart Foundation Centre of Research Excellence, Cardiovascular Division, London SE5 9NU, UK.
Chen LiKing's College London British Heart Foundation Centre of Research Excellence, Cardiovascular Division, London SE5 9NU, UK.
Bin ZhouLaboratory of Molecular Translational Medicine.
Huaqin SunKey Laboratory of Obstetric & Gynecologic and Pediatric Diseases and Birth Defects of Ministry of Education.
Victoria KoullourouKing's College London British Heart Foundation Centre of Research Excellence, Cardiovascular Division, London SE5 9NU, UK.
Ian HoltWolfson Centre for Inherited Neuromuscular Disease, RJAH Orthopaedic Hospital, Oswestry SY10?7AG, UK and Institute for Science and Technology in Medicine, Keele University, ST5?5BG, UK.
Megan J PuckelwartzCenter for Genetic Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
Derek T WarrenKing's College London British Heart Foundation Centre of Research Excellence, Cardiovascular Division, London SE5?9NU, UK.
Robert HaywardKing's College London British Heart Foundation Centre of Research Excellence, Cardiovascular Division, London SE5?9NU, UK.
Ziyuan LinKey Laboratory of Obstetric & Gynecologic and Pediatric Diseases and Birth Defects of Ministry of Education.
Lin ZhangLaboratory of Molecular Translational Medicine.
Glenn E MorrisWolfson Centre for Inherited Neuromuscular Disease, RJAH Orthopaedic Hospital, Oswestry SY10?7AG, UK and Institute for Science and Technology in Medicine, Keele University, ST5?5BG, UK.
Elizabeth M McNallyCenter for Genetic Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.
Sue ShackletonDepartment of Molecular and Cell Biology, University of Leicester, Leicester LE1?9HN, UK.
Li RaoDepartment of Cardiology, West China Hospital of Sichuan University, Chengdu 610041, China.
Catherine M ShanahanKing's College London British Heart Foundation Centre of Research Excellence, Cardiovascular Division, London SE5?9NU, UK.
Qiuping ZhangKing's College London British Heart Foundation Centre of Research Excellence, Cardiovascular Division, London SE5?9NU, UK.
King's College London · GBSichuan University · CNCenter for Translational Molecular Medicine · NLNorthwestern University · USBritish Heart Foundation · GBKeele University · GBRobert Jones and Agnes Hunt Orthopaedic Hospital · GBUniversity of Leicester · GBWest China Hospital of Sichuan University · CNWest China Second University Hospital of Sichuan University · CN

Funding

Training and education CoreU54AR052646 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI MCNALLY, ELIZABETH M, SWEENEY, H LEE · 2005 to 2020
$24.1M
Cardiomyopathy Genomes ProjectR01HL128075 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI MCNALLY, ELIZABETH M, NOBREGA, MARCELO A. · 2015 to 2023
$5.3M
British Heart Foundation PG/11/58/29004British Heart Foundation PG/11/71/29091British Heart Foundation PG/16/68/31991British Heart Foundation RG/11/14/29056NHLBI NIH HHS R01 HL128075NIAMS NIH HHS U54 AR052646
6 · The paper itself

Abstract

Nesprins-1 and -2 are highly expressed in skeletal and cardiac muscle and together with SUN (Sad1p/UNC84)-domain containing proteins and lamin A/C form the LInker of Nucleoskeleton-and-Cytoskeleton (LINC) bridging complex at the nuclear envelope (NE). Mutations in nesprin-1/2 have previously been found in patients with autosomal dominant Emery-Dreifuss muscular dystrophy (EDMD) as well as dilated cardiomyopathy (DCM). In this study, three novel rare variants (R8272Q, S8381C and N8406K) in the C-terminus of the SYNE1 gene (nesprin-1) were identified in seven DCM patients by mutation screening. Expression of these mutants caused nuclear morphology defects and reduced lamin A/C and SUN2 staining at the NE. GST pull-down indicated that nesprin-1/lamin/SUN interactions were disrupted. Nesprin-1 mutations were also associated with augmented activation of the ERK pathway in vitro and in hearts in vivo. During C2C12 muscle cell differentiation, nesprin-1 levels are increased concomitantly with kinesin light chain (KLC-1/2) and immunoprecipitation and GST pull-down showed that these proteins interacted via a recently identified LEWD domain in the C-terminus of nesprin-1. Expression of nesprin-1 mutants in C2C12 cells caused defects in myoblast differentiation and fusion associated with dysregulation of myogenic transcription factors and disruption of the nesprin-1 and KLC-1/2 interaction at the outer nuclear membrane. Expression of nesprin-1α2 WT and mutants in zebrafish embryos caused heart developmental defects that varied in severity. These findings support a role for nesprin-1 in myogenesis and muscle disease, and uncover a novel mechanism whereby disruption of the LINC complex may contribute to the pathogenesis of DCM.

Indexed as

AnimalsCardiomyopathy, DilatedCell Culture TechniquesCytoskeletal ProteinsCytoskeletonHumansKinesinsLamin Type AMembrane ProteinsMicrofilament ProteinsMicrotubule-Associated ProteinsMuscle DevelopmentMuscular Dystrophy, Emery-DreifussMutationNerve Tissue ProteinsNuclear EnvelopeCytoskeletal ProteinsKinesinsKLC1 protein, humanLamin Type AMembrane ProteinsMicrofilament ProteinsMicrotubule-Associated ProteinsNerve Tissue ProteinsNuclear ProteinsSYNE1 protein, human

Identifiers

PMID28398466
PMCPMC5458344
OpenAlexW2609183531

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.